Oligino T - Search Results

1

Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect.

Natsume A, Mata M, Wolfe D, Oligino T, Goss J, Huang S, Glorioso J, Fink DJ. Natsume A, et al. Among authors: oligino t. J Neurotrauma. 2002 Jan;19(1):61-8. doi: 10.1089/089771502753460240. J Neurotrauma. 2002. PMID: 11852979

2

Rapid method for construction of recombinant HSV gene transfer vectors.

Krisky DM, Marconi PC, Oligino T, Rouse RJ, Fink DJ, Glorioso JC. Krisky DM, et al. Among authors: oligino t. Gene Ther. 1997 Oct;4(10):1120-5. doi: 10.1038/sj.gt.3300497. Gene Ther. 1997. PMID: 9415320

3

Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.

Yamada M, Oligino T, Mata M, Goss JR, Glorioso JC, Fink DJ. Yamada M, et al. Among authors: oligino t. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):4078-83. doi: 10.1073/pnas.96.7.4078. Proc Natl Acad Sci U S A. 1999. PMID: 10097166 Free PMC article.

4

Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion.

Yamada M, Natsume A, Mata M, Oligino T, Goss J, Glorioso J, Fink DJ. Yamada M, et al. Among authors: oligino t. Exp Neurol. 2001 Apr;168(2):225-30. doi: 10.1006/exnr.2000.7597. Exp Neurol. 2001. PMID: 11259110

5

Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.

Natsume A, Mata M, Goss J, Huang S, Wolfe D, Oligino T, Glorioso J, Fink DJ. Natsume A, et al. Among authors: oligino t. Exp Neurol. 2001 Jun;169(2):231-8. doi: 10.1006/exnr.2001.7671. Exp Neurol. 2001. PMID: 11358438

6

Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors.

Wechuck JB, Ozuer A, Goins WF, Wolfe D, Oligino T, Glorioso JC, Ataai MM. Wechuck JB, et al. Among authors: oligino t. Biotechnol Bioeng. 2002 Jul 5;79(1):112-9. doi: 10.1002/bit.10310. Biotechnol Bioeng. 2002. PMID: 17590937

7

Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.

Krisky DM, Marconi PC, Oligino TJ, Rouse RJ, Fink DJ, Cohen JB, Watkins SC, Glorioso JC. Krisky DM, et al. Among authors: oligino tj. Gene Ther. 1998 Nov;5(11):1517-30. doi: 10.1038/sj.gt.3300755. Gene Ther. 1998. PMID: 9930305

8

Engineering herpes simplex virus vectors for CNS applications.

Wolfe D, Goins WF, Yamada M, Moriuchi S, Krisky DM, Oligino TJ, Marconi PC, Fink DJ, Glorioso JC. Wolfe D, et al. Among authors: oligino tj. Exp Neurol. 1999 Sep;159(1):34-46. doi: 10.1006/exnr.1999.7158. Exp Neurol. 1999. PMID: 10486173 Review. No abstract available.

9

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

Marconi P, Krisky D, Oligino T, Poliani PL, Ramakrishnan R, Goins WF, Fink DJ, Glorioso JC. Marconi P, et al. Among authors: oligino t. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11319-20. doi: 10.1073/pnas.93.21.11319. Proc Natl Acad Sci U S A. 1996. PMID: 8876133 Free PMC article. Review. No abstract available.

10

In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.

Oligino T, Poliani PL, Marconi P, Bender MA, Schmidt MC, Fink DJ, Glorioso JC. Oligino T, et al. Gene Ther. 1996 Oct;3(10):892-9. Gene Ther. 1996. PMID: 8908503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters